Cutaneous Squamous Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Cutaneous Squamous Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Ex Vivo Cutaneous SCC [NA]
A clinical trial update indicates recruiting for an ex vivo study related to cutaneous squamous cell carcinoma at Rigshospitalet in Denmark,…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Exercise to Boost Response to Checkpoint Blockade Immunotherapy [EARLY_Phase 1]
This clinical trial update describes an Early Phase 1 study at H. Lee Moffitt Cancer Center examining whether exercise can boost responses t…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Pucotenlimab Combined With Becotatug Vedotin in Advanced Cutaneous Squamous Cell Carcinoma [Phase 2]
This document provides an update on a Phase 2 clinical trial evaluating the combination of pucotenlimab and becotatug vedotin for advanced c…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Correlation of Dermoscopic Findings With Histopathological Features and Invasion Depth in Cutaneous Squamous Cell Carcinoma
This clinical trial study investigates the correlation between dermoscopic features and histopathological invasion depth in cutaneous squamo…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Radiotherapy in Combination With Atezolizumab in Locally Advanced Borderline Resectable or Unresectable Cutaneous SCC [Phase 1]
Phase 1 trial evaluating radiotherapy in combination with atezolizumab for locally advanced, borderline resectable, or unresectable cutaneou…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Impact of Preoperative High-Frequency Ultrasound Cutaneous Lesion Extent Assessment on Excision Margin Positivity in Head and Neck Skin Cancer, and the Relationship Between Preoperative Assessment Methods, Inadequate Excision Margins, and Tumor Recurrence
A clinical trial update evaluating whether preoperative high-frequency ultrasound assessment of skin lesion extent reduces excision-margin p…
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Stereotactic Post-operative Radiotherapy for Intraparotid Metastatic Cutaneous Squamous Cell Carcinoma [NA]
A clinical study evaluating stereotactic post-operative radiotherapy for intraparotid metastatic cutaneous squamous cell carcinoma is curren…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors [Phase 1]
A Phase 1 trial evaluating in situ immunomodulation using CDX-301, CDX-1140, and Poly-ICLC with radiation therapy in patients with unresecta…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Thermotherapy in Addition to SOC Palliative Radiotherapy [NA]
A clinical trial update indicating recruitment for a study evaluating thermotherapy added to standard of care palliative radiotherapy in pat…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Liquid Biomarker Study in Melanoma and Non-Melanoma Skin Cancers
A clinical trial update announcing a liquid biomarker study in melanoma and non-melanoma skin cancers that is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: Neoadjuvant Nivolumab and Relatlimab in Cutaneous Squamous Cell Carcinoma [Phase 2]
Phase 2 neoadjuvant trial evaluating the combination of nivolumab and relatlimab for cutaneous squamous cell carcinoma is currently recruiti…
-
CLINICAL_TRIALS research · 2025-12-12Clinical Trial Update: Tumor-Informed ctDNA Testing for MRD Following Treatment of Squamous Cell Carcinoma
Clinical trial update on tumor-informed ctDNA testing for minimal residual disease after treatment in head and neck squamous cell carcinoma …
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Clinical Study Protocol for Cutaneous SCC for Immunocompromised Patients [NA]
This document describes a clinical study protocol evaluating alpha-radiation therapy for cutaneous squamous cell carcinoma in immunocompromi…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: A Clinical Study to Assess the Efficacy and Safety of Alpha DaRT224 for the Treatment of Patients With Recurrent Cutaneous Squamous Cell Carcinoma [NA]
A clinical trial is evaluating Alpha DaRT224 for recurrent cutaneous squamous cell carcinoma, focusing on efficacy and safety. The study is …
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Expanded Access Use of Cemiplimab in Patients With Solid Tumors
Expanded access update on cemiplimab for patients with solid tumors, including non-small cell lung cancer, basal cell carcinoma, and cutaneo…
-
CLINICAL_TRIALS research · 2025-10-16Clinical Trial Update: Study of the Monoclonal Antibody IMT-009 in Patients With Advanced Solid Tumors or Lymphomas [Phase 1, Phase 2]
Clinical trial update describing a Phase 1/2 study of the monoclonal antibody IMT-009 in various advanced solid tumors and lymphomas, with t…
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: A Phase 0 Window of Opportunity Trial of Intratumoral Seasonal Influenza Immunization in Cutaneous Squamous Cell Carcinoma (CSCC) Patients Awaiting Curative Excision [EARLY_Phase 1]
This early-phase clinical trial is evaluating intratumoral administration of a seasonal influenza vaccine in patients with cutaneous squamou…
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: Personalised Immunotherapy Platform
Clinical trial update for a personalised immunotherapy platform; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-10Clinical Trial Update: Next-gen Flow Cytometry to Find Immune Profiles, Treatment Response, and Toxicity Markers in Skin Cancer Patients Treated With Cemiplimab.
Clinical trial investigating immune profiles, treatment response, and toxicity markers in skin cancer patients treated with cemiplimab using…
-
CLINICAL_TRIALS research · 2025-08-29Clinical Trial Update: MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors [Phase 1]
Phase 1 study of MEM-288 oncolytic virus in advanced solid tumors, evaluating MEM-288 alone and in combination with standard-of-care therapy…
-
CLINICAL_TRIALS research · 2025-08-15Clinical Trial Update: Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors [Phase 1]
Phase 1 study evaluating safety and tolerability of BCA101 as monotherapy and in combination in EGFR-driven advanced solid tumors. The trial…
-
CLINICAL_TRIALS research · 2025-08-14Clinical Trial Update: Cemiplimab Before and After Surgery for the Treatment of High Risk Cutaneous Squamous Cell Cancer [Phase 1]
Phase 1 trial of cemiplimab (Libtayo) given before and after surgery for high-risk cutaneous squamous cell carcinoma is currently recruiting…
-
CLINICAL_TRIALS research · 2025-08-03Clinical Trial Update: A Study of Tolododekin Alfa (ANK-101) in Renal Allograft Recipients With High Risk Cutaneous Squamous Cell Carcinoma [Phase 1]
Phase 1 study investigating Tolododekin Alfa (ANK-101) in renal allograft recipients with high-risk cutaneous squamous cell carcinoma, statu…
-
CLINICAL_TRIALS research · 2025-07-03Clinical Trial Update: Microbiota Transplant to Cancer Patients Who Have Failed Immunotherapy Using Faeces From Clinical Responders [Phase 2]
A Phase 2 clinical trial at Oslo University Hospital is testing fecal microbiota transplantation from clinical responders in cancer patients…
-
CLINICAL_TRIALS research · 2025-06-19Clinical Trial Update: An Open-label Study Using ASP-1929 Photoimmunotherapy in Combination With Anti-PD1 Therapy in EGFR Expressing Advanced Solid Tumors [Phase 1, Phase 2]
Open-label Phase 1/2 trial evaluating ASP-1929 photoimmunotherapy in combination with anti-PD1 therapy for EGFR-expressing advanced solid tu…